2020 Updated Asthma Guidelines

Asthma is one of the most common conditions we see in primary care and can result in significant morbidity and mortality if not diagnosed and managed optimally. The National Heart, Lung, and Blood Institute (NHLBI) has sponsored a consensus panel to develop clinical practice guidelines for child and adult asthma since 1989. The guidelines were updated at the end of 2020 for the first time in over a decade.


Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended adult (anyone over 18 years old) and children 18 years and younger, immunization schedule to ensure that the schedules reflects current recommendations for the licensed vaccines.

Thyroid Disease

This activity will provide the participant with the latest up-to-date information for thyroid disease and review of treatment for both subclinical and overt disease. Discussion will include management of therapeutic options as well as counseling, screening, and monitoring the pregnant thyroid patient.

Ebola: Facts, Fears, and Hope

Dr. Able discusses the history, symptoms and latest updates for Ebola. Recent releases from the Centers for Disease Control and Prevention are also highlighted.

Perspective on COPD

COPD is a common, preventable, and treatable disease characterized by progressive persistent airflow limitation. COPD is clearly a cause of morbidity and mortality and results in an ever-increasing economic and social burden.

Difficult-to-treat asthma

Patients with asthma should gain knowledge, skills, and confidence to assume the major role in the day-to-day management of their disease. This activity will highlight specific patient education and health literacy tools, including the personalized asthma action plan, written in language that the patient can read and understand.

Inhaler Devices

The clinical practice of medicine involves a continual balance of evidence-based information applied to clinically complex scenarios amongst the human factors of fears, preferences, results, and economics. This continuing education module focuses on the clinicians’ skills, resources, tools and approaches for more optimal choice, use, and thus better outcomes, involving inhaled medications.

COPD in Primary Care

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and 12th leading cause of morbidity in the United States. This activity will address the use of spirometry for diagnosis and treatment of COPD, explore the benefits of exercise and pulmonary rehabilitation, and identify treatment options for optimal patient outcomes.

Asthma for Primary Care

Asthma is a chronic disease associated with inflammation in the airways. The inflammation is strongly linked with airway hyperresponsiveness and the typical asthma symptoms. Understanding the full spectrum of the pathology and the pathogenesis of asthma should be used for defining the treatment options.

Hereditary Angioedema

Hereditary angioedema (HAE) is an autosomal-dominant disorder that is characterized by recurrent attacks of facial, abdominal, genital, or peripheral skin edema without accompanying urticaria. These episodes can be life-threatening if they involve the larynx or the upper airway. Angioedema can be associated with other medical problems, including infection, connective tissue disorders, and malignancy.